IceCure Medical (ICCM) Net Equity Issued and Repurchased (2021 - 2026)

IceCure Medical (ICCM) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased rose 38.06% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $16.4 million, a 83.74% increase from a year earlier, with the FY2024 full-year figure at $9.2 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased was $3.5 million for Q1 2026 at IceCure Medical, down from $9.2 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $9.2 million in Q3 2025 and troughed at $1.1 million in Q4 2024.
• A 3-year average of $3.4 million and a median of $2.8 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 173.15% in 2025, down 9.69% in 2025.
• Over 3 years, Net Equity Issued and Repurchased stood at $1.1 million in 2024, then surged by 733.33% to $9.2 million in 2025, then tumbled by 61.45% to $3.5 million in 2026.
• The last three Net Equity Issued and Repurchased figures came in at $3.5 million (Q1 2026), $9.2 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.